Prospects of the clinical utilization of melatonin

Pharmacology, Toxicology and Pharmaceutical Science

• Melatonin 100%
• Animal 11%
• Receptor 5%
• Diseases 5%
• Neoplasm 5%
• Nitric Oxide 5%
• Human 5%
• Oxygen 5%
• Immunoglobulin 5%
• Melatonin Receptor 5%
• Side Effect 5%
• Diarrhea 5%
• Neurotoxicity 5%
• Antioxidant 5%
• Free Radical 5%
• Scavenger 5%
• Blood-Brain Barrier 5%
• Septic Shock 5%
• Immune Deficiency 5%
• Mammal 5%
• Interleukin 2 5%
• Somnolence 5%
• Malignant Neoplasm 5%
• Stomach Ulcer 5%
• Headache 5%
• Migraine 5%
• Parkinson Disease 5%
• Clinical Study 5%
• Colitis 5%
• Alzheimer Disease 5%
• Cytostatic Agent 5%
• Human Study 5%
• Hemorrhagic Shock 5%
• Bird 5%
• Contraceptive Agent 5%
• Incidence 5%
• Symptom 5%
• Blindness 5%
• Controlled Release 5%
• Jet Lag 5%

Neuroscience

• Melatonin 100%
• Sleep 11%
• Eicosanoid Receptor 5%
• In Vitro 5%
• In Vivo 5%
• Intravenous Immunoglobulin 5%
• Migraine 5%
• Nitric Oxide 5%
• Antioxidant 5%
• Blood Brain Barrier 5%
• Free Radicals 5%
• Somnolence 5%
• Interleukin 2 5%
• Melatonin Receptor 5%
• Treatment of Parkinson's Disease 5%
• Sleep Quality 5%
• Treatment of Alzheimer's Disease 5%
• Stroke 5%
• Neurotoxicity 5%

Immunology and Microbiology

• Development 11%
• Drowsiness 11%
• Immunodeficiency 5%
• Intravenous Immunoglobulin 5%
• Low Drug Dose 5%
• Human 5%
• Animal Experiment 5%
• Interleukin 2 5%
• Mammal 5%
• Animal 5%
• Blood Brain Barrier 5%
• Scavenger 5%
• Light 5%
• Artery 5%
• Body Temperature 5%
• Periodicity 5%
• Bird 5%
• Cardiovascular System 5%
• Colitis 5%
• Digestive System 5%
• Reproduction 5%
• Rhythm 5%
• Sleep Quality 5%
• Jet Lag 5%
• Tissues 5%
• Regulatory Mechanism 5%
• Immunity 5%
• Brain 5%
• Incidence 5%
• Organ 5%
• Heat Loss 5%
• Somnolence 5%